Blog
Artisans, Hipsters, and Suits
Earlier this month, consumer packaged-goods giant Nestle SA (NASDAQOTH: NSRGY) announced a deal to snap up a controlling stake in upscale coffee-purveyor Blue Bottle Coffee Company for a sum....
Desperate Times Call for Desperate Measures
On this MarketFoolery podcast, host Chris Hill and Motley Fool Asset Management's Bill Barker put Nike's (NYSE: NKE) bad quarter into context (because it could be worse); consider what....
Short-Sellers Take Aim at Health Insurance Innovations Again, Sending Shares Crashing 24% Today
Health Insurance Innovations (NASDAQ: HIIQ) shareholders have endured a horrible September that included short-sellers questioning the long-term viability of its business model and most recently,....
Should You Invest in This Marijuana ETF?
Exchange traded funds (ETFs) can be a good way to invest in a particular industry without having to pick individual stocks. With the medical marijuana industry still in its infancy and the drug....
Another Solar Manufacturer Goes Private
For the second time this year, a U.S.-traded Chinese solar manufacturer has agreed to go private in a sale to its CEO. ReneSola (NYSE: SOL) will sell its solar manufacturing capacity and....
What Happened in the Stock Market Today
Stocks gained on Thursday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) closing up and the S&P 500 (SNPINDEX: ^GSPC) setting a new record.Data source: Yahoo! Finance.Homebuilders....
Why Roku, Inc. Stock Skyrocketed Today
Shares of Roku Inc. (NASDAQ: ROKU) soared 67.9% on Thursday, as investors cheered the streaming-video platform specialist on its first day as a publicly traded company.Yesterday Roku priced its....
Why Gilead Sciences, Pier 1 Imports, and PetMed Express Slumped Today
The market remained kind to investors on Thursday, as the S&P 500 climbed into record territory amid modest advances for most major benchmarks. Positive data on durable goods orders helped....
Why BlackBerry, AbbVie, and bluebird bio Jumped Today
Thursday was a quiet day on Wall Street, with major benchmarks remaining close to the unchanged level. Sentiment among market participants remained relatively favorable in the aftermath of the....
4 Beaten-Down Oil Stocks That Could Make Huge Moves if Crude Continues Its Momentum
Crude oil has quietly rebounded 20% off its most recent low, which means it's now technically in a bull market. That said, while this rally brought the U.S. oil benchmark, WTI, to around $52.50 a....
Accenture Plc Ends Fiscal 2017 on a High Note
Consulting and outsourcing provider Accenture (NYSE: ACN) reported fiscal fourth-quarter earnings on Thursday morning. Here's what you need to know.MetricQ4 2017Continue readingSource: Fool.com
How the Bronco Will Affect Ford's Sales
The Bronco was discontinued in 1996, but recently Ford (NYSE: F) announced a new line of Broncos that are set to come out in 2020 -- and consumers are excited.In this segment from Industry Focus:....
Why GM's New Crossovers Are Selling Like Hotcakes
While many of the biggest automakers experienced declines last quarter, General Motors (NYSE: GM) saw a 7.5% boost in August, and that's in no small part because of its new crossovers.In this....
Automakers' Record Highs Are Coming to an End
The auto industry is cyclical, and this year is showing the end of years of growth. In this segment from Industry Focus: Industrials, analyst Sarah Priestley and senior auto specialist John....
Why AMD’s Latest Win Should Give NVIDIA Sleepless Nights
Advanced Micro Devices (NASDAQ: AMD) and NVIDIA (NASDAQ: NVDA) have been locked in an intense battle for GPU (graphics processing unit) supremacy. AMD has momentum on its side as its market share....
Apple Music Subscribers Climb to 30 Million
In a new interview with Billboard, Apple Music lead Jimmy Iovine said the tech giant's streaming service subscriber count has hit a fresh high of over 30 million subscribers, climbing from 27....
5 Essential Themes in PepsiCo's Upcoming Earnings
Through the first nine months of this year, PepsiCo Inc. (NYSE: PEP) stock has turned in a credible performance, generating a total return of nearly 10%, which is just a few percentage points shy....
Buffalo Wild Wings' Risky New Promo Is Working Perfectly
If you've visited your local Buffalo Wild Wings (NASDAQ: BWLD) in recent weeks, you may have noticed that one of its primary promotions has changed. Rather than offering half-priced traditional....
2 Catalysts That Could Send Energy Transfer Partners LP Soaring
After several tough years, Energy Transfer Partners (NYSE: ETP) finally seemed to turn the corner last quarter. The pipeline company reported that distributable cash flow not only stopped sliding....
Better Buy: Bellicum Pharmaceuticals, Inc. vs. bluebird bio
This version of our ongoing better buy series pits two development-stage biotechs, Bellicum Pharmaceuticals (NASDAQ: BLCM) and bluebird bio (NASDAQ: BLUE), against each other. The companies have....
3 Value Stocks for Bold Investors
There are a number of reasons seemingly good stocks get beaten down. Sometimes, those reasons represent outstanding opportunities for investors bold enough to take a chance. Three that come to....
Amazon.com Just Expanded Its Smart Home Lead Over Apple and Google
Amazon.com (NASDAQ: AMZN) has emerged as a somewhat unexpected leader in the smart home market, thanks to Alexa and its growing portfolio of Echo devices. Rivals like Apple (NASDAQ: AAPL) and....
This Drug Pricing Scheme Could Be Making Your Medicine More Expensive
Biosimilars that are as safe and effective as expensive brand-name biologics could significantly reduce drug prices and healthcare spending, but only if they win support from insurers.....
Better Buy: CenturyLink, Inc. vs. Frontier Communications
These are challenging times for regional telcos, and Frontier Communications (NASDAQ: FTR) and CenturyLink (NYSE: CTL) investors know the pain. CenturyLink has seen its stock slide 19% this year,....
Here's Why Spectrum Pharmaceuticals, Inc. Is Surging Today
Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), a biopharmaceutical company primarily focused on cancer and blood-based disorders, are rising in response to some surprising early stage....